WaferGen Bio-systems Announces Supply Agreement With Reprogenetics for Next-Generation Sequencing (NGS) Automated Solutions Focused on In-Vitro Fertilization (IVF)

FREMONT, Calif. — WaferGen Bio-systems (NASDAQ:WGBS) announced today that the Company has signed a supply agreement with Reprogenetics, the largest U.S. genetics laboratory specializing in Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD), for use of

WaferGen’s Apollo 324TM Next Generation Sequencing (NGS) sample preparation system. The Apollo 324TM will enable automation of NGS library preparation for PGS testing used in in-vitro fertilization (IVF).

The Apollo 324TM is a compact and versatile platform that enables rapid and full walk- away library prep automation for NGS applications. It combines precise liquid handling and proven chemistries to provide a streamlined sample-to-answer solution for robust library preparation on all major NGS platforms.

“We look forward to supporting the leader in PGS and PGD testing, as Reprogenetics continues to deliver high-quality personalized care in the IVF field,” said Rollie Carlson, CEO of WaferGen Bio-systems. “The Apollo 324TM NGS sample preparation system will enable improved workflow and will create additional resources for Reprogenetics’ transition of their PGS services to NGS.”

About WaferGen

WaferGen Bio-systems, Inc. is a biotechnology company that offers innovative genomic technology solutions for single-cell analysis and clinical research. The ICELL8TM Single- Cell System is a revolutionary platform which can isolate thousands of single cells and processes specific cells for analysis, including Next Generation Sequencing. The system has demonstrated unbiased isolation of up to 1,800 single cells ranging from 5-100 ?m in size on a single chip, including single cells from solid tumors, brain cells, pulmonary airway cells, and multiple cell lines. The SmartChip platform can be used for profiling and validating molecular biomarkers, and can perform massively-parallel single-plex PCR for one-step target enrichment and library preparation for clinical NGS. These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell level in the life sciences, pharmaceutical and clinical laboratory industries.

< | >